tm logo

Monitor this mark

View On USPTO

EXFORGEHCT
Live/Registered
REGISTERED AND RENEWED

on 23 Mar 2022

Last Applicant/ Owned by

Novartis AG

CH 4002

Basel

CH

4002

Serial Number

85139553 filed on 28th Sep 2010

Registration Number

4091926 registered on 24th Jan 2012

in the Principal Register

Correspondent Address

Maury M. Tepper, III

Maury M. Tepper, III

3724 BENSON DR

RALEIGH NC 27609-7321

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

EXFORGEHCT

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment and prevention of metabolic diseases and disorders

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment and prevention of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment and prevention of metabolic diseases and disorders

First Use Date in General

01st May 2009

First Use Date in Commerce

01st May 2009

Mark Details

Serial Number

No 85139553

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
23rd Mar 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
23rd Mar 2022REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
23rd Mar 2022REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
21st Mar 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11th Nov 2021TEAS SECTION 8 & 9 RECEIVED
24th Jan 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06th Jan 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
06th Jan 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
06th Jan 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10th Dec 2017TEAS SECTION 8 & 15 RECEIVED